Autophagy dysfunction is a common feature in neurodegenerative disorders characterized by accumulation of toxic protein aggregates. Increasing evidence has demonstrated that activation of TFEB (transcription factor EB), a master regulator of autophagy and lysosomal biogenesis, can ameliorate neurotoxicity and rescue neurodegeneration in animal models. Currently known TFEB activators are mainly inhibitors of MTOR (mechanistic target of rapamycin [serine/threonine kinase]), which, as a master regulator of cell growth and metabolism, is involved in a wide range of biological functions. Thus, the identification of TFEB modulators acting without inhibiting the MTOR pathway would be preferred and probably less deleterious to cells. In this study, a synthesized curcumin derivative termed C1 is identified as a novel MTOR-independent activator of TFEB. Compound C1 specifically binds to TFEB at the N terminus and promotes TFEB nuclear translocation without inhibiting MTOR activity. By activating TFEB, C1 enhances autophagy and lysosome biogenesis in vitro and in vivo. Collectively, compound C1 is an orally effective activator of TFEB and is a potential therapeutic agent for the treatment of neurodegenerative diseases.

A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition / Song, Ju Xian; Sun, Yue Ru; Peluso, Ivana; Zeng, Yu; Yu, Xing; Lu, Jia Hong; Xu, Zheng; Wang, Ming Zhong; Liu, Liang Feng; Huang, Ying Yu; Chen, Lei Lei; Durairajan, Siva Sundara Kumar; Zhang, Hong Jie; Zhou, Bo; Zhang, Hong Qi; Lu, Aiping; Ballabio, Andrea; Medina, Diego L; Guo, Zhihong; Li, Min; MEDINA SANABRIA, Diego Luis. - In: AUTOPHAGY. - ISSN 1554-8627. - (2016), pp. 0-00. [10.1080/15548627.2016.1179404]

A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition

BALLABIO, ANDREA;MEDINA SANABRIA, Diego Luis
Co-ultimo
2016

Abstract

Autophagy dysfunction is a common feature in neurodegenerative disorders characterized by accumulation of toxic protein aggregates. Increasing evidence has demonstrated that activation of TFEB (transcription factor EB), a master regulator of autophagy and lysosomal biogenesis, can ameliorate neurotoxicity and rescue neurodegeneration in animal models. Currently known TFEB activators are mainly inhibitors of MTOR (mechanistic target of rapamycin [serine/threonine kinase]), which, as a master regulator of cell growth and metabolism, is involved in a wide range of biological functions. Thus, the identification of TFEB modulators acting without inhibiting the MTOR pathway would be preferred and probably less deleterious to cells. In this study, a synthesized curcumin derivative termed C1 is identified as a novel MTOR-independent activator of TFEB. Compound C1 specifically binds to TFEB at the N terminus and promotes TFEB nuclear translocation without inhibiting MTOR activity. By activating TFEB, C1 enhances autophagy and lysosome biogenesis in vitro and in vivo. Collectively, compound C1 is an orally effective activator of TFEB and is a potential therapeutic agent for the treatment of neurodegenerative diseases.
2016
A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition / Song, Ju Xian; Sun, Yue Ru; Peluso, Ivana; Zeng, Yu; Yu, Xing; Lu, Jia Hong; Xu, Zheng; Wang, Ming Zhong; Liu, Liang Feng; Huang, Ying Yu; Chen, Lei Lei; Durairajan, Siva Sundara Kumar; Zhang, Hong Jie; Zhou, Bo; Zhang, Hong Qi; Lu, Aiping; Ballabio, Andrea; Medina, Diego L; Guo, Zhihong; Li, Min; MEDINA SANABRIA, Diego Luis. - In: AUTOPHAGY. - ISSN 1554-8627. - (2016), pp. 0-00. [10.1080/15548627.2016.1179404]
File in questo prodotto:
File Dimensione Formato  
Song_Autophagy.pdf

accesso aperto

Tipologia: Versione Editoriale (PDF)
Licenza: Accesso privato/ristretto
Dimensione 2.4 MB
Formato Adobe PDF
2.4 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/634133
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 137
  • ???jsp.display-item.citation.isi??? 125
social impact